StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Inovio Pharmaceuticals, Inc.
NasdaqCM:INO
Sector
Location
Market Cap
USD 69.31 M
Share Price
USD 1.36
Avg Daily Volume
1,184,131
Change (1 day)
-2.16%
Change (1 year)
-87.68%
Change (YTD)
-25.68%
Inovio Pharmaceuticals, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2023: USD -132.10 M
Inovio Pharmaceuticals, Inc. Free Cash Flow is USD -132.10 M for the Trailing 12 Months (TTM) ending December 31, 2023, a -38.61% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Inovio Pharmaceuticals, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -215.18 M.
-
Inovio Pharmaceuticals, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -179.50 M.
Competitors
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Moderna, Inc.
USD 33.64
MRNA
-0.64
-1.87%
Swedish Orphan Biovitrum AB (publ)
USD 29.78
SOBI.ST
-0.91
-2.98%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.86
300122.SZ
-0.00
-0.16%
Ionis Pharmaceuticals, Inc.
USD 41.73
IONS
-0.65
-1.53%
Rhythm Pharmaceuticals, Inc.
USD 86.70
RYTM
-2.34
-2.63%
Vaxcyte, Inc.
USD 35.93
PCVX
-0.31
-0.85%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.97
1877.HK
-0.03
-1.06%
Hualan Biological Engineering Inc.
USD 2.22
002007.SZ
+0.01
0.65%
NewAmsterdam Pharma Company N.V.
USD 21.54
NAMS
-0.48
-2.18%
Ligand Pharmaceuticals Incorporated
USD 121.70
LGND
-3.28
-2.62%
Apellis Pharmaceuticals, Inc.
USD 19.44
APLS
-0.09
-0.46%
Apogee Therapeutics, Inc.
USD 38.14
APGE
-0.43
-1.11%
Bavarian Nordic A/S
USD 28.24
BAVA.CO
-0.51
-1.79%
Adaptive Biotechnologies Corporation
USD 11.82
ADPT
-0.26
-2.15%
Immunocore Holdings plc
USD 35.02
IMCR
-0.43
-1.21%
ARS Pharmaceuticals, Inc.
USD 17.69
SPRY
-0.29
-1.61%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Moderna, Inc.
USD 33.64
MRNA
-0.64
-1.87%
Swedish Orphan Biovitrum AB (publ)
USD 29.78
SOBI.ST
-0.91
-2.98%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.86
300122.SZ
-0.00
-0.16%
Ionis Pharmaceuticals, Inc.
USD 41.73
IONS
-0.65
-1.53%
Rhythm Pharmaceuticals, Inc.
USD 86.70
RYTM
-2.34
-2.63%
Vaxcyte, Inc.
USD 35.93
PCVX
-0.31
-0.85%
Shanghai Junshi Biosciences Co., Ltd.
USD 2.97
1877.HK
-0.03
-1.06%
Hualan Biological Engineering Inc.
USD 2.22
002007.SZ
+0.01
0.65%
NewAmsterdam Pharma Company N.V.
USD 21.54
NAMS
-0.48
-2.18%
Ligand Pharmaceuticals Incorporated
USD 121.70
LGND
-3.28
-2.62%
Apellis Pharmaceuticals, Inc.
USD 19.44
APLS
-0.09
-0.46%
Apogee Therapeutics, Inc.
USD 38.14
APGE
-0.43
-1.11%
Bavarian Nordic A/S
USD 28.24
BAVA.CO
-0.51
-1.79%
Adaptive Biotechnologies Corporation
USD 11.82
ADPT
-0.26
-2.15%
Immunocore Holdings plc
USD 35.02
IMCR
-0.43
-1.21%
ARS Pharmaceuticals, Inc.
USD 17.69
SPRY
-0.29
-1.61%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%